Amy Schacterle
Net worth: 239 988 $ as of 30/05/2026
Net worth: 239 988 $ as of 30/05/2026
Presently, Amy Schacterle occupies the position of Senior VP-Research & Development Strategy at SAGE Therapeutics, Inc. In her past career Dr. Schacterle was Vice President-Regulatory Affairs at Sunovion Pharmaceuticals, Inc. She received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate and a graduate degree from the University of Virginia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/01/2026 | 92,303 ( 0.13% ) | 239 988 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | General Counsel | 05/11/2024 |
| Companies | Position | End |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2023 |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | General Counsel | 31/12/2013 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions